Skip to content

Perspective Therapeutics CATX Change in Other Liabilities

Change in Other Liabilities at other companies

Lantheus Holdings logo
Lantheus HoldingsLNTH
$84K-86.9%
Precigen logo
PrecigenPGEN
-$28K
Spyre Therapeutics, Inc. logo
Spyre Therapeutics, Inc.SYRE
$36K-98.1%
Septerna, Inc. logo
Septerna, Inc.SEPN
$100K
Roivant Sciences logo
Roivant SciencesROIV
-$252K-230%

Other financials

Income statement

See full
Revenue$2.2M+27.3%
Gross profit$738.0K+78.3%
Operating income-$28.3M-29.5%
Net income-$26.2M-44.1%
EPS (diluted)-$0.250.0%

Balance sheet

See full
Cash & equivalents$54.0M+21.5%
Total debt$4.2M+10.9%
Total equity$347.4M+22.1%
Total assets$410.8M+24.7%

Cash flow

See full
Operating cash flow-$31.5M-45.8%
CapEx$6.9M+47.3%
Free cash flow-$38.3M-46.1%

Valuation

See full
Market cap$342.14M+33.2%
Enterprise value$292.34M+35.2%
P/S34.2×+19.6×

Profitability

See full
Gross margin33.1%-7.1pp
Operating margin-292.7%-553pp
Net margin-218.4%-781pp
FCF margin-1,073.3%

Returns & leverage

See full
Return on equity-35.2%+2.3pp
Debt / equity0.0×
Current ratio8.7×-8.3×

Where this comes from

Reported directly by Perspective Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities.

The official record: Perspective Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Perspective Therapeutics's change in other liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Perspective Therapeutics's change in other liabilities?
Perspective Therapeutics (CATX) reported change in other liabilities of $51K in Q1 2026.
How has Perspective Therapeutics's change in other liabilities changed year-over-year?
Perspective Therapeutics's change in other liabilities decreased by 43.3% year-over-year, from $90K to $51K.
What is the long-term trend for Perspective Therapeutics's change in other liabilities?
Over 2 years (2022 to 2025), Perspective Therapeutics's change in other liabilities has grown at a 256.8% compound annual growth rate (CAGR), from $26K to $331K.
What does change in other liabilities mean?
Change in miscellaneous liabilities affecting operating cash flow.